Antibodies specific to glycoprotein (gp) of ebolavirus and uses for the treatment and diagnosis of ebola virus infection

The present invention relates to antibodies or fragments thereof that specifically bind to glycoprotein (GP) of Ebola virus, and to their use for treating and diagnosing Ebola virus disease.

Keywords: neutralizing monoclonal antibody
Patent Application number: EP15305348.3
Inventors:
Olivier REYNARDViktor VOLCHKOV
Publications:
J Infect Dis. 2015 Oct 1;212 Suppl 2:S372-8. doi: 10.1093/infdis/jiv303. Epub 2015 Aug 1.

Reference:

BIO14444-T1

Business Developper
contact
Inserm Transfert
Inserm Transfert
Business Developer
Patent filling date: 2015-03-06

You might also be interested in